アスピリン,貧乏人のスタチン?

[Passive smoking and the risk of coronary heart disease].

Nederlands tijdschrift voor geneeskunde·2004

[Reperfusion therapy for patients with an acute myocardial infarct with ST-segment elevation: fibrinolysis versus transport to a cardiac center for primary angioplasty].

Nederlands tijdschrift voor geneeskunde·2003

[Resuscitations in the hospital: reporting using the Utstein-style form and a study of 183 patients in the St. Radboud University Medical Center, Nijmegen, the Netherlands, between 1997-2000].

Nederlands tijdschrift voor geneeskunde·2003

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

European heart journal·2001

Warfarin for ischemic heart disease.

Cardiology in review·2001

Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.

Journal of the American College of Cardiology·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Open forum infectious diseases·2026

Long-Term Outcomes of Living-Related Kidney Donors Over 26 Years: A Study of 154 Cases From the Ibn Sina University Hospital Center in Rabat, Morocco.

Cureus·2026

The Role of Downstream Kynurenine Pathway Metabolites in the Modulation of Cardiovascular Disease Development in Chronic Kidney Disease.

International journal of tryptophan research : IJTR·2026

Association between Chinese herbal medicine and the composite outcome of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a prospective cohort study.

Journal of geriatric cardiology : JGC·2026

Health economic evaluation of left atrial appendage closure in patients with atrial fibrillation and at high risk for stroke and bleeding: a study protocol.

Frontiers in health services·2026

Hypertension and Postoperative Outcomes: A Retrospective Cohort Study.

Anesthesiology research and practice·2026

関連する実験動画

アスピリン,貧乏人のスタチン?

関連する概念動画

[Passive smoking and the risk of coronary heart disease].

[Reperfusion therapy for patients with an acute myocardial infarct with ST-segment elevation: fibrinolysis versus transport to a cardiac center for primary angioplasty].

[Resuscitations in the hospital: reporting using the Utstein-style form and a study of 183 patients in the St. Radboud University Medical Center, Nijmegen, the Netherlands, between 1997-2000].

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

Warfarin for ischemic heart disease.

Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Long-Term Outcomes of Living-Related Kidney Donors Over 26 Years: A Study of 154 Cases From the Ibn Sina University Hospital Center in Rabat, Morocco.

The Role of Downstream Kynurenine Pathway Metabolites in the Modulation of Cardiovascular Disease Development in Chronic Kidney Disease.

Association between Chinese herbal medicine and the composite outcome of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a prospective cohort study.

Health economic evaluation of left atrial appendage closure in patients with atrial fibrillation and at high risk for stroke and bleeding: a study protocol.

Hypertension and Postoperative Outcomes: A Retrospective Cohort Study.

関連する実験動画

アスピリン,貧乏人のスタチン?

関連する概念動画

関連記事